Cochrane · systematic review · CD002207

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

Mattick, RP, Breen, C, Kimber, J, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library

Drugs and AlcoholAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
8
current version
GRADE rated
8
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 6 · 75%High 2 · 25%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Summary of findings: comparison between flexible‐dose methadone and buprenorphine

Population: People with opioid dependence.
5 questions
OutcomeEffectEvidenceStatus / GRADE
Retention in treatment
RR 0.83 [0.73, 0.95]11 studies · 1391 participantsHigh
Morphine‐positive urines
no estimate extracted8 studies · 1027 participantsModerate
Self‐reported heroin use
no estimate extracted4 studies · 501 participantsModerate
Cocaine‐positive urines
SMD 0.16 studies · 919 participantsModerate
Benzodiazepine‐positive urines
SMD 0.056 studies · 859 participantsModerate

Summary of findings for the comparison between high‐dose buprenorphine and placebo

Population: People with opioid dependence.
3 questions
OutcomeEffectEvidenceStatus / GRADE
Retention in treatment
RR 1.82 [1.15, 2.9]5 studies · 1001 participantsHigh
Morphine‐positive urines
no estimate extracted3 studies · 729 participantsModerate
Benzodiazepine‐positive urines
no estimate extracted2 studies · 336 participantsModerate